Resitu Medical is developing a minimally invasive, single-use, ultrasound guided device that uses diathermy to extract the tissue sample with minimal bleeding.
Potential health economic benefits
The instrument will be easy to use and, by providing the entire lesion for analysis, will result in reduced need for re-sampling and revisits for the patient. It connects to standard diathermy equipment and vacuum is created in the tube, avoiding initial investment in vacuum generating floor units and at the same time saving space in the clinic. The method requires only local anaesthesia, which means time and cost savings for the clinic and could reduce complications as well as anxiety for the patient. The minimally invasive method could be performed in an out-patient setting and risks for post operative care are reduced. The Resitu technology has the potential to shorten the process of breast cancer management substantially by removing the need for open surgery altogether.
Provides large tissue samples
Reducing risks for ambiguous tissue analysis or incorrect result. Large tissue samples also ensure that multiple analyses, including tumour typing and sequencing can be done.